Relative Virulence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Among Vaccinated and Unvaccinated Individuals Hospitalized With SARS-CoV-2

BACKGROUND: The rapid development of safe and effective vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been a singular scientific achievement. Confounding due to health-seeking behaviors, circulating variants, and differential testing by vaccination status may bias...

Descripción completa

Detalles Bibliográficos
Autores principales: Grima, Alicia A, Murison, Kiera R, Simmons, Alison E, Tuite, Ashleigh R, Fisman, David N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9278128/
https://www.ncbi.nlm.nih.gov/pubmed/35616115
http://dx.doi.org/10.1093/cid/ciac412

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9278128/
https://www.ncbi.nlm.nih.gov/pubmed/35616115
http://dx.doi.org/10.1093/cid/ciac412

Ejemplares similares